C12Y 108/01007
Glutathione-disulfide reductase , i.e. glutathione reductase
Official title: Glutathione-disulfide reductase (1.8.1.7), i.e. glutathione reductase (NADPH)
C12Y108/01007 (Glutathione-disulfide reductase , i.e. glutathione reductase) appears on 21 US grants and 35 published applications in this corpus.
Search patents in C12Y- Granted patents
- 21
- Published applications
- 35
- Assignees
- 23
- Inventors
- 55
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 0 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 4 |
| 2019 | 1 | 0 |
| 2020 | 4 | 4 |
| 2021 | 0 | 3 |
| 2022 | 4 | 3 |
| 2023 | 2 | 5 |
| 2024 | 0 | 3 |
| 2025 | 3 | 3 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates12 May 2026US 12,624,375 B2Northwestern University
- Thrombolytic and neuro/vasculoprotective nanoconjugates9 Sep 2025US 12,409,147 B2The Cleveland Clinic Foundation
- E. coli strains having an oxidative cytoplasm9 Sep 2025US 12,410,393 B2Sutro Biopharma, Inc.
- Processes for producing reduced coenzyme Q1011 Feb 2025US 12,221,645 B2Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.
- Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates15 Aug 2023US 11,725,224 B2Northwestern University
- E. coli strains having an oxidative cytoplasm19 Mar 2026US 2026/0078337 A1Sutro Biopharma, Inc.
- Thrombolytic and neuro/vasculoprotective nanoconjugates8 Jan 2026US 2026/0007614 A1The Cleveland Clinic Foundation
- Method for producing useful substance18 Dec 2025US 2025/0382653 A1Kaneka Corporation
- Novel variant of stress protein and method for preparing l-aromatic amino acid using the same15 May 2025US 2025/0154540 A1Daesang Corporation
- Enzyme electrode, enzymatic reaction device, enzymatic reaction method, modified protein, and modified protein production method8 May 2025US 2025/0146042 A1Panasonic Intellectual Property Management Co., Ltd.
Most cited
By later US patents
- Inducible expression system9US 10,465,197 B2AbiSci, LLC · 2019
- Method of expressing proteins with disulfide bridges with enhanced yields and activity4US 8,802,394 B22014
- Reparatives for chemosurgery and laser (thermal) therapy3US 6,630,442 B12003
- Inducible coexpression system3US 9,617,335 B2AbSci LLC · 2017
- E. coli strains having an oxidative cytoplasm2US 11,407,975 B2Sutro Biopharma, Inc. · 2022